Bioprocessing Summit
Date: August 18-21, 2025
Location: Boston, MA
JOIN US
Whether you’re in the early stages of development or advancing towards commercialization, Catalent offers comprehensive, end-to-end support for your cell & gene therapy programs. Connect with our experts to discuss how partnering with Catalent can accelerate the development of your next innovative treatment.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
August 19th 2025 – 1:00 PM – 1:30 PM
Session Title: GPEx® Lightning Technology: Overcoming Challenges to Deliver Difficult to Express Proteins
Speaker: Nicholas Sanek, Group Lead – Cell Line Development, Catalent
August 20, 2025 – 12:10 PM – 12:40 PM
Session Title: Unpacking FDA’s Platform Technology Designation Program: Key Considerations for Sponsors Partnering with CDMOs
Speaker: Philip Wills, Chief Commercial Officer, Cell & Gene Therapy, Catalent
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.
